1. Stimulus bill packs a windfall for FDA and COVID-19 drug developers — Roche nixes Tecentriq bladder cancer accelerated approval — AI uncovers Lilly's Olumiant as potential Alzheimer's treatment See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

reimbursement

Discussion in 'Millennium Laboratories' started by Anonymous, Oct 22, 2014 at 4:41 PM.

  1. #1 Anonymous, Oct 22, 2014 at 4:41 PM
    Anonymous

    Anonymous Guest

    I have heard that the codes are going to get slammed and/or bundled (and slammed). rumor has them down to about 200 $ for a bundled.

    Any ideas/thoughts/comments? is this true. if so, how can the industry survive this type of hit.
     
    Quote
  2. #2 Anonymous, Oct 25, 2014 at 5:20 PM
    Anonymous

    Anonymous Guest

    Are you kidding? How can an industry that does $50 worth of testing make it on $200 versus the overcharging they currently do? The industry is overdue for this change.
     
    Quote
  3. #3 Anonymous, Oct 26, 2014 at 12:52 PM
    Anonymous

    Anonymous Guest

    big cuts
     
    Quote
  4. #4 Anonymous, Nov 4, 2014 at 8:53 PM
    Anonymous

    Anonymous Guest

    That is almost a certainty considering the abuse in Urine Tox. Just as G0431 is a single code for Qualitative screen by immunoassay there will be a single code for CDA (Comprehensive Drug Analysis) by LCMS, and it probably will be in the $200 - 400 range. If you split and code individual drugs that will be then be considered unbundling. This it the current CMS/Medicare thinking. My guess will be commercial insurance will subsequently follow in their footsteps.
     
    Quote
  5. #5 Anonymous, Nov 10, 2014 at 2:14 PM
    Anonymous

    Anonymous Guest

    Any news on when the final payments will be announced for the bundled codes?
     
    Quote
Reply to Thread